White House’s global COVID jab distribution plan hits obstacles | Coronavirus pandemic news

White House’s global COVID jab distribution plan hits obstacles | Coronavirus pandemic news

Facebook
Twitter
LinkedIn

[ad_1]

The remaining 55 million doses of COVID vaccine will be distributed, but President Biden’s deadline will not be met in time.

The Biden administration revealed on Monday Distribution plan With 55 million doses of the coronavirus vaccine, officials said that logistical challenges delayed the commitment to share 80 million doses with other countries at the end of June.

In a fact sheet released on Monday, the White House stated that most of the 55 million photos will pass Kovacs Global sharing mechanism. Approximately 14 million doses will be sent to countries in Latin America and the Caribbean, including Brazil, Argentina, and Colombia, while 16 million doses will be sent to Asian countries including India. Approximately 10 million doses of vaccine will be shipped to Africa and selected countries will be coordinated with the African Union.

The remaining approximately 25% of the dose will be shared directly with countries in Latin America, Asia, Africa, the Middle East and Europe.

Ground crews unload a batch of Johnson & Johnson vaccines from South Africa at Toronto Pearson Airport in Mississauga, Ontario, Canada [File: Carlos Osorio/Reuters]

The White House stated in the fact sheet: “The sharing of millions of American vaccines with other countries marks a major commitment by the US government.”

“Just like we did in our domestic response, we will act as quickly as possible while complying with the regulatory and legal requirements of the United States and the host country to promote safe and reliable transportation of vaccines across international borders.”

But President Joe Biden is expected to be unable to deliver on his promises 80 million The COVID-19 vaccine will be vaccinated abroad at the end of June.

White House Press Secretary Jen Psaki said that the doses produced in the United States are ready and the delay is due to regulatory and logistical obstacles.

Psaki said at a regular press conference on Monday: “We found that the biggest challenge is actually not supply-we have a lot of doses to share with the world-but it is a huge logistical challenge.”

A woman was vaccinated against COVID-19 at a pharmacy in Schwanksville, Pennsylvania [File: Hannah Beier/Reuters]

So far, fewer than 10 million doses have been shipped from the United States to other countries, including 2.5 million doses Sent to Taiwan on the weekend, about 1 million doses It was delivered to Mexico, Canada and South Korea earlier this month.

Psaki said that once countries are ready to receive these doses and the government will resolve complex logistical issues, including vaccination supplies such as syringes and alcohol preparation pads, refrigeration of doses, customs procedures, and even language barriers, the goods will be sent out.

Psaki said she does not know how many doses will be delivered by the end of this month.

As demand for vaccines has fallen sharply in recent weeks, the United States has been shipping “excessive” doses of vaccines-these vaccines are not needed in the United States.more than 177 million Americans At least one shot has been received.

Earlier this month, Biden announced that in addition to the 80 million doses of vaccine that his government will share globally, the United States will also purchase 500 million doses Pfizer will donate to all parts of the world next year, and the first delivery is expected to take place in August.

Taiwanese workers unload Moderna vaccines shipped from the United States in Taoyuan, Taiwan [Ann Wang/Reuters]

The White House also announced the first 25 million doses For export from existing federal stockpiles of Pfizer, Moderna and Johnson & Johnson vaccines, some of which have already begun shipping.

Biden initially promised to provide other countries with all 60 million The dose of AstraZeneca vaccine produced in the United States has not been authorized in the United States, but has been widely approved worldwide. The US Food and Drug Administration has conducted a safety review for several weeks, and the export of AstraZeneca’s dosage has been banned.



[ad_2]

Source link

More to explorer